Clinical Trials
25 trialsNCT02840227 2024-06-20
The Effect of Combined General/Regional Anesthesia on Cancer Recurrence in Patients Having Lung Cancer Resections
The Cleveland Clinic
Phase NA Withdrawn
NCT05431582 2023-06-15
Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT00499291 2023-05-25
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors
Eastern Cooperative Oncology Group
Phase NA Withdrawn
NCT04555564 2022-08-18
Tc99m Macroaggregated Albumin Bronchial Artery Study
Johns Hopkins University
Phase NA Withdrawn
NCT04685551 2022-07-26
Improving Survivorship Among Minority Cancer Dyads
Charles Drew University of Medicine and Science
Phase NA Withdrawn
NCT03431415 2021-08-24
RAXSIA
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Phase NA Withdrawn
NCT04464967 2021-05-12
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
NKGen Biotech, Inc.
Phase 1/2 Withdrawn
NCT02030184 2019-10-17
Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas
University of Maryland, Baltimore
Phase 1/2 Withdrawn
NCT03334487 2018-12-26
Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer
AbbVie
Phase 3 Withdrawn
NCT00352950 2018-09-06
Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer
Amgen
Phase 1 Withdrawn
NCT00588263 2018-02-19
Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer
Memorial Sloan Kettering Cancer Center
Withdrawn
NCT02947113 2017-11-30
HYPOLAN
The Netherlands Cancer Institute
Phase 2 Withdrawn
NCT02425072 2017-08-10
NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer
University of Kentucky
Phase 2 Withdrawn
NCT03042013 2017-07-11
A Study for Subjects Who Are Participating in an Astellas-sponsored ASP8273 Study
Astellas Pharma Inc
Phase 2 Withdrawn
NCT01936961 2017-06-27
I-CREST
Western Regional Medical Center
Phase NA Withdrawn
NCT02661100 2016-12-07
A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients
Case Comprehensive Cancer Center
Phase 1/2 Withdrawn
NCT00755157 2015-10-07
Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer
University Hospital of Crete
Phase 2 Withdrawn
NCT00733252 2015-10-02
Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease
Case Comprehensive Cancer Center
Withdrawn
NCT00704392 2015-08-20
Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors
Exelixis
Phase 1 Withdrawn
NCT00891761 2015-04-17
A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy
GlaxoSmithKline
Phase 3 Withdrawn
NCT01611584 2014-11-13
A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer
Dartmouth-Hitchcock Medical Center
Phase 1 Withdrawn
NCT02034097 2014-05-19
A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer
GlaxoSmithKline
Phase 2 Withdrawn
NCT00606970 2013-05-07
Safety Assessment of Lactobacillus Fermented Extract in Cancer Patients Undergoing Chemotherapy
New Hope Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT00653367 2012-02-24
Evaluation of Chronic Pain After Nerve Section During Thoracotomy
Rigshospitalet, Denmark
Phase NA Withdrawn
NCT01000896 2010-02-04
Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel
AstraZeneca
Phase 1 Withdrawn